Showing 1 - 3 results of 3 for search 'C. SIBLEY', query time: 0.02s Refine Results
  1. 1
    POS-145 ATRASENTAN IN PATIENTS WITH PROTEINURIC GLOMERULAR DISEASES (THE AFFINITY STUDY)

    POS-145 ATRASENTAN IN PATIENTS WITH PROTEINURIC GLOMERULAR DISEASES (THE AFFINITY STUDY) by C. SIBLEY, M. Camargo, A. King, S. Lewis, J. Tolentino, A. Glicklich

    Published 2021-04-01
    Get full text
    Article
  2. 2
    POS-144 A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, PARALLEL GROUP SAFETY AND BIOAVAILABILITY STUDY OF BION-1301 ADMINISTERED BY INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ROUTES

    POS-144 A PHASE 1, OPEN-LABEL, RANDOMIZED, SINGLE-DOSE, PARALLEL GROUP SAFETY AND BIOAVAILABILITY STUDY OF BION-1301 ADMINISTERED BY INTRAVENOUS (IV) AND SUBCUTANEOUS (SC) ROUTES by C. SIBLEY, A. Mittan, A. Endsley, S. Roy, J. Lee, S. Lewis, J. Lo, A. Glicklich

    Published 2021-04-01
    Get full text
    Article
  3. 3
    Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines.

    Identification of Gene Expression Differences between Lymphangiogenic and Non-Lymphangiogenic Non-Small Cell Lung Cancer Cell Lines. by Erin Regan, Robert C Sibley, Bercin Kutluk Cenik, Asitha Silva, Luc Girard, John D Minna, Michael T Dellinger

    Published 2016-01-01
    Get full text
    Article

Search Tools: